CeriBell Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 39/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 26.00.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
CeriBell Inc's Score
Industry at a Glance
Industry Ranking
39 / 208
Overall Ranking
113 / 4568
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
8
analysts
Strong Buy
Current Rating
26.000
Target Price
+28.59%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
CeriBell Inc Highlights
StrengthsRisks
CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 152.47% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 65.44M.
Fairly Valued
The company’s latest PE is -15.13, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 30.92M shares, decreasing 0.09% quarter-over-quarter.
CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.
Ticker SymbolCBLL
CompanyCeriBell Inc
CEOChao (Xingjuan)
Websitehttps://ceribell.com/
FAQs
What is the current price of CeriBell Inc (CBLL)?
The current price of CeriBell Inc (CBLL) is 21.420.
What is the symbol of CeriBell Inc?
The ticker symbol of CeriBell Inc is CBLL.
What is the 52-week high of CeriBell Inc?
The 52-week high of CeriBell Inc is 27.215.
What is the 52-week low of CeriBell Inc?
The 52-week low of CeriBell Inc is 10.010.
What is the market capitalization of CeriBell Inc?
The market capitalization of CeriBell Inc is 793.58M.
What is the net income of CeriBell Inc?
The net income of CeriBell Inc is -40.45M.
Is CeriBell Inc (CBLL) currently rated as Buy, Hold, or Sell?
According to analysts, CeriBell Inc (CBLL) has an overall rating of --, with a price target of 26.000.
What is the Earnings Per Share (EPS TTM) of CeriBell Inc (CBLL)?
The Earnings Per Share (EPS TTM) of CeriBell Inc (CBLL) is -1.407.